Autres langues Tianjin Ringpu Bio-Technology Co.,Ltd.

Actions

300119

CNE100000TV1

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 08/10/2026			Varia. 5j.	Varia. 1 janv.
16,62 ^CNY	-0,84%		-0,84%	-11,45%

25/08	Tianjin Ringpu Bio-Technology Co.,Ltd. publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
27/04	Tianjin Ringpu Bio-Technology Co.,Ltd. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

25/08	Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
10/06	Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million.
27/04	Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
30/03	Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
30/03	Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026
27/03	Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding
28/11	Ringpu Bio-Technology Secures Registration For Feline Vaccine
30/10/25	Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd.
24/10/25	Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
25/08/25	Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
14/07/25	Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit
14/06/25	Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million.
30/04/25	Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024.
30/04/25	Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million.
25/04/25	Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend on A Shares for the Year 2024, Payable on 21 May 2025
25/04/25	Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
03/04/25	Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Cash Distribution for the Year 2024
02/04/25	Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024.
02/04/25	Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
02/01/25	Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024.
14/12/24	Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire 56.31% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for approximately CNY 104 million.
14/12/24	Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire an additional 15% stake in Tianjin Ruihe Biotechnology Co., Ltd. from Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 1.
14/12/24	Tianjin Ringpu Bio-Technology Co.,Ltd. completed the acquisition of 40% stake in Tianjin Ruihe Biotechnology Co., Ltd. from Tianjin Ruipu Pharmaceutical Technology Co., Ltd. for CNY 1.
08/11/24	Tianjin Ringpu Bio-Technology Plans to Acquire 15% Stake in Zhongrui Huapu Technology
08/11/24	Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire 15% stake in Zhongrui Huapu Technology Co., Ltd. from Li Shoujun, Liang Wu, Su Yalada, Li Xudong, Bao Haili, and Zhou Zhonghua for approximately CNY 130 million.